Fisher Funds Management LTD Increases Stock Holdings in HCA Healthcare, Inc. $HCA

Fisher Funds Management LTD boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 48.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 119,412 shares of the company’s stock after acquiring an additional 38,876 shares during the period. HCA Healthcare comprises 1.3% of Fisher Funds Management LTD’s portfolio, making the stock its 21st largest holding. Fisher Funds Management LTD owned approximately 0.05% of HCA Healthcare worth $50,893,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the stock. Chung Wu Investment Group LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth about $27,000. Clearstead Trust LLC lifted its stake in shares of HCA Healthcare by 311.8% during the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after purchasing an additional 53 shares during the period. Ameriflex Group Inc. purchased a new position in HCA Healthcare during the second quarter worth about $27,000. Harbor Capital Advisors Inc. increased its position in HCA Healthcare by 82.9% during the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after purchasing an additional 34 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth approximately $40,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

HCA opened at $469.08 on Tuesday. HCA Healthcare, Inc. has a 1-year low of $295.00 and a 1-year high of $520.00. The business has a 50 day moving average price of $480.68 and a two-hundred day moving average price of $431.78. The company has a market capitalization of $107.04 billion, a price-to-earnings ratio of 18.13, a price-to-earnings-growth ratio of 1.29 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same quarter in the prior year, the firm posted $4.90 earnings per share. The company’s revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 29th. Stockholders of record on Monday, December 15th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on HCA. Morgan Stanley downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective for the company. in a research report on Monday, December 15th. Jefferies Financial Group raised their target price on HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research note on Tuesday, October 28th. Bank of America increased their price target on HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a report on Monday, October 27th. KeyCorp increased their target price on HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a research note on Monday, October 27th. Finally, Stephens upped their price target on shares of HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Fifteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $487.00.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.